Published in BMC Complement Altern Med on September 23, 2014
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature (1999) 12.32
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell (2002) 9.10
Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med (1997) 5.72
Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med (1999) 3.07
Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem (2004) 2.66
Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest (1993) 2.52
Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest (2004) 2.31
NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest (2008) 2.29
NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J Biol Chem (2007) 2.22
Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol Rev (2009) 2.01
Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev (2005) 1.81
Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation. J Biol Chem (2004) 1.64
MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood (2006) 1.60
RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis. EMBO J (2005) 1.53
Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood (2005) 1.38
Neuroprotective effect of Alpinia oxyphylla Miq. fruits against glutamate-induced apoptosis in cortical neurons. Toxicol Lett (2003) 1.34
Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors. Arthritis Res Ther (2011) 1.33
Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss. J Bone Miner Res (2009) 1.31
Bone turnover markers: use in osteoporosis. Nat Rev Rheumatol (2012) 1.25
Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem Biophys Res Commun (2006) 1.13
Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling. J Biol Chem (2009) 1.11
Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Mol Pharmacol (2009) 1.10
Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother Res (2007) 1.09
Antiplatelet effects of Cyperus rotundus and its component (+)-nootkatone. J Ethnopharmacol (2011) 0.97
Ethanolic extract of fructus Alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Cell Mol Neurobiol (2011) 0.96
Anti-ulcer effect in rats of bitter cardamon constituents. Chem Pharm Bull (Tokyo) (1990) 0.94
Anti-allergic activity of sesquiterpenes from the rhizomes of Cyperus rotundus. Arch Pharm Res (2011) 0.93
Effect of Alpinia oxyphylla fruit extract on compound 48/80-induced anaphylactic reactions. Am J Chin Med (2001) 0.90
Alternative therapies for the prevention and treatment of osteoporosis. Nutr Rev (2012) 0.88
In vitro antioxidant and cytotoxic properties of ethanol extract of Alpinia oxyphylla fruits. Pharm Biol (2013) 0.87
Analysis of nine compounds from Alpinia oxyphylla fruit at different harvest time using UFLC-MS/MS and an extraction method optimized by orthogonal design. Chem Cent J (2013) 0.87
Inhibitory regulation of osteoclast differentiation by interleukin-3 via regulation of c-Fos and Id protein expression. J Cell Physiol (2012) 0.83
(+)-Nootkatone and (+)-valencene from rhizomes of Cyperus rotundus increase survival rates in septic mice due to heme oxygenase-1 induction. J Ethnopharmacol (2011) 0.82
Nootkatone, a characteristic constituent of grapefruit, stimulates energy metabolism and prevents diet-induced obesity by activating AMPK. Am J Physiol Endocrinol Metab (2010) 0.80
Anti-diarrheal constituents of Alpinia oxyphylla. Fitoterapia (2013) 0.79
Ethanol extract of Atractylodes macrocephala protects bone loss by inhibiting osteoclast differentiation. Molecules (2013) 0.77
v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med (2006) 3.78
TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis. Nat Med (2006) 2.44
The specificity and topology of chromatin interaction pathways in yeast. Mol Cell (2011) 2.04
Synthetic tyrosyl gallate derivatives as potent melanin formation inhibitors. Bioorg Med Chem Lett (2007) 1.78
CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis. Cancer Res (2012) 1.55
OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J Clin Invest (2011) 1.38
The tec family tyrosine kinase Btk Regulates RANKL-induced osteoclast maturation. J Biol Chem (2008) 1.29
Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling. J Biol Chem (2009) 1.11
Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Mol Pharmacol (2009) 1.10
Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis. Arthritis Rheum (2008) 1.10
Tmem64 modulates calcium signaling during RANKL-mediated osteoclast differentiation. Cell Metab (2013) 1.09
A key role for Chd1 in histone H3 dynamics at the 3' ends of long genes in yeast. PLoS Genet (2012) 1.02
Free radical theory of aging: implications in male infertility. Urology (2009) 1.01
Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. Biochem Pharmacol (2013) 1.01
The fission yeast Jmj2 reverses histone H3 Lysine 4 trimethylation. J Biol Chem (2007) 1.01
NHE10, an osteoclast-specific member of the Na+/H+ exchanger family, regulates osteoclast differentiation and survival [corrected]. Biochem Biophys Res Commun (2008) 1.00
Composition-tuned ZnO--CdSSe core--shell nanowire arrays. ACS Nano (2010) 0.95
Cutting edge: requirement for TRAF6 in the induction of T cell anergy. J Immunol (2008) 0.95
The anti-osteoporotic effect of Yijung-tang in an ovariectomized rat model mediated by inhibition of osteoclast differentiation. J Ethnopharmacol (2012) 0.95
Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription. J Bone Miner Res (2011) 0.94
Effects of thresholding techniques on microCT-based finite element models of trabecular bone. J Biomech Eng (2007) 0.93
A Novel Herbal Medicine KIOM-MA Exerts an Anti-Inflammatory Effect in LPS-Stimulated RAW 264.7 Macrophage Cells. Evid Based Complement Alternat Med (2012) 0.91
Tanshinone IIA suppresses inflammatory bone loss by inhibiting the synthesis of prostaglandin E2 in osteoblasts. Eur J Pharmacol (2008) 0.90
Synovial cyst in the cervical region causing severe myelopathy. Yonsei Med J (2004) 0.90
Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration. Blood (2004) 0.90
Geometry-dependent terahertz emission of silicon nanowires. Opt Express (2010) 0.90
Aristolochia manshuriensis Kom inhibits adipocyte differentiation by regulation of ERK1/2 and Akt pathway. PLoS One (2012) 0.87
Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe. Arthritis Rheum (2011) 0.86
Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1. Exp Mol Med (2006) 0.86
cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction. Biochem Biophys Res Commun (2010) 0.85
AG490, a Jak2-specific inhibitor, induces osteoclast survival by activating the Akt and ERK signaling pathways. Mol Cells (2008) 0.85
Sonophoresis using ultrasound contrast agents for transdermal drug delivery: an in vivo experimental study. Ultrasound Med Biol (2012) 0.85
Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge. Biochem Pharmacol (2004) 0.84
Inhibitory Effects of Hwangryunhaedok-Tang in 3T3-L1 Adipogenesis by Regulation of Raf/MEK1/ERK1/2 Pathway and PDK1/Akt Phosphorylation. Evid Based Complement Alternat Med (2013) 0.84
Tumor necrosis factor-alpha induces differentiation of human peripheral blood mononuclear cells into osteoclasts through the induction of p21(WAF1/Cip1). Biochem Biophys Res Commun (2005) 0.84
Room-temperature ferromagnetism and terahertz emission of Mn-doped InGaAs and GaAsSb nanowires. Nanotechnology (2010) 0.83
The role of nacreous factors in preventing osteoporotic bone loss through both osteoblast activation and osteoclast inactivation. Biomaterials (2012) 0.83
[Panton-Valentine leukocidin positive Staphylococcus aureus isolated from blood in Korea]. Korean J Lab Med (2007) 0.83
Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL. Eur J Pharmacol (2009) 0.83
Mechanical properties of blood-mixed polymethylmetacrylate in percutaneous vertebroplasty. Asian Spine J (2009) 0.82
Suppression of the invasive potential of highly malignant tumor cells by KIOM-C, a novel herbal medicine, via inhibition of NF-κB activation and MMP-9 expression. Oncol Rep (2013) 0.82
Low-level laser therapy using the minimally invasive laser needle system on osteoporotic bone in ovariectomized mice. Med Eng Phys (2012) 0.82
Hippocampal levels of phosphorylated protein kinase A (phosphor-S96) are linked to spatial memory enhancement by SGS742. Hippocampus (2009) 0.81
The effects of minimally invasive laser needle system on suppression of trabecular bone loss induced by skeletal unloading. Lasers Med Sci (2013) 0.81
High incidence of complement C9 deficiency in Koreans. Ann Clin Lab Sci (2005) 0.80
Low-intensity ultrasound stimulation prevents osteoporotic bone loss in young adult ovariectomized mice. J Orthop Res (2011) 0.80
Prediction of antiarthritic drug efficacies by monitoring active matrix metalloproteinase-3 (MMP-3) levels in collagen-induced arthritic mice using the MMP-3 probe. Mol Pharm (2014) 0.80
MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice. Eur J Pharmacol (2012) 0.80
Hwangryun-Haedok-Tang Fermented with Lactobacillus casei Suppresses Ovariectomy-Induced Bone Loss. Evid Based Complement Alternat Med (2012) 0.80
Lactobacillus fermentation enhances the inhibitory effect of Hwangryun-haedok-tang in an ovariectomy-induced bone loss. BMC Complement Altern Med (2013) 0.80
Food- and gender-dependent pharmacokinetics of paeoniflorin after oral administration with Samul-tang in rats. J Ethnopharmacol (2012) 0.80
Antithrombotic and antiplatelet activities of Soshiho-tang extract. BMC Complement Altern Med (2013) 0.80
Orally active desulfated low molecular weight heparin and deoxycholic acid conjugate, 6ODS-LHbD, suppresses neovascularization and bone destruction in arthritis. J Control Release (2012) 0.80
ATP6v0d2 deficiency increases bone mass, but does not influence ovariectomy-induced bone loss. Biochem Biophys Res Commun (2010) 0.79
Tetragonal phase germanium nanocrystals in lithium ion batteries. ACS Nano (2013) 0.79
[Evaluation of Abbott Fourth Generation HIV Antigen and Antibody Assays.]. Korean J Lab Med (2006) 0.79
The role of phagocytosis in IL-8 production by human monocytes in response to lipoproteins on Staphylococcus aureus. Biochem Biophys Res Commun (2011) 0.78
In Vitro and In Vivo Genotoxicity Assessment of Aristolochia manshuriensis Kom. Evid Based Complement Alternat Med (2012) 0.78
Sauchinone attenuates oxidative stress-induced skeletal muscle myoblast damage through the down-regulation of ceramide. Biol Pharm Bull (2011) 0.78
Bilateral asymmetry in microarchitecture of trabecular bone in male C57BL/6 mouse tibia: implication for experimental sample size estimations. Proc Inst Mech Eng H (2013) 0.78
Mice transgenic for reduced folate carrier: an animal model of Down syndrome? Amino Acids (2008) 0.78
Acute oral toxicity and genotoxicity of Dryopteris crassirhizoma. J Ethnopharmacol (2013) 0.78
Changes of hippocampal signaling protein levels during postnatal brain development in the rat. Hippocampus (2008) 0.78
Alteration patterns of trabecular bone microarchitectural characteristics induced by osteoarthritis over time. Clin Interv Aging (2012) 0.78
5-Lipoxygenase mediates RANKL-induced osteoclast formation via the cysteinyl leukotriene receptor 1. J Immunol (2012) 0.77
Deterioration of bone quality in the tibia and fibula in growing mice during skeletal unloading: gender-related differences. J Biomech Eng (2011) 0.77
Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic charge. Biomaterials (2012) 0.77
Inhibitory effect of panduratin A isolated from Kaempferia panduarata Roxb. on melanin biosynthesis. Phytother Res (2010) 0.77
Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption. BMC Complement Altern Med (2013) 0.77
Ethanol extract of Atractylodes macrocephala protects bone loss by inhibiting osteoclast differentiation. Molecules (2013) 0.77
Synthesis of laboratory Ultrasound Contrast Agents. Molecules (2013) 0.76
The effect of initial serum neuron-specific enolase level on clinical outcome in acute carotid artery territory infarction. Yonsei Med J (2002) 0.76
Water Extract of Dryopteris crassirhizoma Attenuates Bone Loss by Suppressing Osteoclast Differentiation and Function. Evid Based Complement Alternat Med (2013) 0.75
[Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates with toxic shock syndrome toxin and staphylococcal enterotoxin C genes]. Korean J Lab Med (2007) 0.75
Changes in microarchitectural characteristics at the tibial epiphysis induced by collagen-induced rheumatoid arthritis over time. Clin Interv Aging (2012) 0.75
Three synthetic routes to single-crystalline PbS nanowires with controlled growth direction and their electrical transport properties. ACS Nano (2010) 0.75
Incorporation of detailed eye model into polygon-mesh versions of ICRP-110 reference phantoms. Phys Med Biol (2015) 0.75
Transport disc distraction osteogenesis for the reconstruction of a calvarial defect. J Craniofac Surg (2009) 0.75
Transport properties of single-crystalline n-type semiconducting PbTe nanowires. Nanotechnology (2009) 0.75
Effect of dissolved organic matter on the growth of algae, Pseudokirchneriella subcapitata, in Korean lakes: the importance of complexation reactions. Ecotoxicol Environ Saf (2008) 0.75
Development of skeletal system for mesh-type ICRP reference adult phantoms. Phys Med Biol (2016) 0.75
GaP-ZnS pseudobinary alloy nanowires. Nano Lett (2014) 0.75
Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression. Am J Chin Med (2015) 0.75
Effect of input waveform pattern and large blood vessel existence on destruction of liver tumor using radiofrequency ablation: finite element analysis. J Biomech Eng (2010) 0.75
Evaluation of the potential clinical application of low-intensity ultrasound stimulation for preventing osteoporotic bone fracture. Ann Biomed Eng (2010) 0.75
New small-intestine modeling method for surface-based computational human phantoms. J Radiol Prot (2016) 0.75